what are the negative side effects of tirzepatide worst semaglutide bad Comparative safety and and tirzepatide: Implications for clinical decision-making in obesity management Ozempic ( semaglutide) is a GLP-1 – Semaglutide Side Effects: A Week-by-Week – Tirzepatide Side Effects: Blood Clots,

Key highlights Tirzepatide is the first dual GLP-1/GIP receptor agonist that offers stronger appetite suppression, improved glycemic control, and provides significantly greater weight loss than single receptor agonists such as semaglutide, liraglutide, and dulaglutide

The general adult weight-management indication includes patients with an initial: BMI of 30 kg/m2 or above, or BMI from 27 kg/m2 to below 30 kg/m2 with at least one weight-related health condition Relevant conditions may include: high blood pressure abnormal cholesterol levels obstructive sleep apnoea cardiovascular disease prediabetes type 2 diabetes Meeting these general criteria does not guarantee that treatment will be prescribed

Li XZ et al

Among these patients, five mutations of the pyruvate dehydrogenase (E1) alpha subunit have been reported previously: H44R, R88S, G89S, R263G, and V389fs [67,68,69,70,71]

Read product labels to verify that health products have been authorized for sale by Health Canada